
New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.
Medrad has developed a second-generation injector of MR contrast media. The new product, called Spectris Solaris, will be available worldwide by March. It features enhancements that provide added control and versatility, according to the company. Solaris
Medrad has developed a second-generation injector of MR contrast media. The new product, called Spectris Solaris, will be available worldwide by March. It features enhancements that provide added control and versatility, according to the company. Solaris is compatible with MR scanners ranging from 0.2T to 2T. The company introduced its first-generation Solaris in 1996.




